Frederik C schreef:
Deze is van gisteren..ook leuk en ik was'm vergeten ROP!
Dr. Smith Lecture to NIH: ROP
From AccuGrowth on YMB:
Re: Dr. Smith Lecture to NIH 6 minutes ago I just listened to the lecture. Minutes 42, 47, and 52 are strong endorsements of IPLEX.
* Dr. Smith says Premacure is completing Phase II and working on starting Phase III for ROP soon. That is different from GA's comments that ROP Phase II will be initiated in Q2 2009. It seems they are further along than previously indicated.
* Safety profile of normal dose IPLEX is good. I was surprised that Dr. Smith said that one injection is sufficient.
* This is the surprise. Dr. Smith is recommending IGF-1 for Diabetes to reduce Retinopathies. She indicated that blindness in this group is growing and impacts working adults. She commented on the earlier study that indicated high dose of IGF-1 can promote unwanted vascular growth. She did not go into detail about BP-3, but the indication is that she likes it.
The lecture was strong enough to move the INSM share price this week. DNA/Roche need to count their spare change from their recent merger to see if they can put a bid in for INSM.
videocast.nih.gov/PastEvents.aspGeluk, F.